Luwad, Nora Ina S.
HRN: 15-83-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
CEFUROXIME 750MG (VIAL)
10/18/2025
10/25/2025
IV
750mg
Q8
CAPMR
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes